Security Snapshot

Anterix Inc. - Common Stock (ATEX) Institutional Ownership

CUSIP: 03676C100

13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

116

Shares (Excl. Options)

16,180,534

Price

$21.83

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
ATEX on Nasdaq
Shares outstanding
18,768,052
Price per share
$35.89
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
16,180,534
Total reported value
$353,310,211
% of total 13F portfolios
0%
Share change
-44,764
Value change
-$760,647
Number of holders
116
Price from insider filings
$35.89
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • ATEX - Anterix Inc. - Common Stock is tracked under CUSIP 03676C100.
  • 116 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 116 to 45 between Q4 2025 and Q1 2026.
  • Reported value moved from $353,310,211 to $71,750,496.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 116 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 03676C100?
CUSIP 03676C100 identifies ATEX - Anterix Inc. - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Anterix Inc. - Common Stock (ATEX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Heard Capital LLC 9.4% $51,528,035 1,741,989 Heard Capital LLC 28 Feb 2025
BlackRock, Inc. 5% -2.4% $35,694,245 -$618,411 934,649 -1.7% BlackRock, Inc. 31 Mar 2026
VANGUARD GROUP INC 5% $20,330,854 931,305 The Vanguard Group 31 Dec 2025
DG Capital Management, LLC 4% -24% $15,985,360 -$4,963,757 744,544 -24% DG Capital Management, LLC 30 Sep 2025

As of 31 Dec 2025, 116 institutional investors reported holding 16,180,534 shares of Anterix Inc. - Common Stock (ATEX). This represents 86% of the company’s total 18,768,052 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Anterix Inc. - Common Stock (ATEX) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Owl Creek Asset Management, L.P. 29% 5,411,776 0% 14% $118,139,070
Heard Capital LLC 9.1% 1,716,738 0% 1.8% $37,476,391
BlackRock, Inc. 5.4% 1,018,275 -1.3% 0% $22,228,954
VANGUARD GROUP INC 5% 931,305 -7.6% 0% $20,330,388
QVT Financial LP 2.7% 503,941 0% 1% $11,001,032
Jefferies Financial Group Inc. 2.4% 454,508 0.08% $9,921,910
MILLENNIUM MANAGEMENT LLC 2.3% 439,946 +1153% 0.01% $9,604,021
GAMCO INVESTORS, INC. ET AL 2.3% 422,470 +32% 0.09% $9,222,520
GARNET EQUITY CAPITAL HOLDINGS, INC. 2.1% 397,395 0% 4.3% $8,675,133
GEODE CAPITAL MANAGEMENT, LLC 1.9% 360,139 -0.33% 0% $7,863,736
STATE STREET CORP 1.8% 333,788 +5.4% 0% $7,286,592
DIMENSIONAL FUND ADVISORS LP 1.7% 324,923 +4.4% 0% $7,092,536
GABELLI FUNDS LLC 1.6% 304,907 +6.5% 0.05% $6,656,120
MARSHALL WACE, LLP 1.6% 291,255 +1.6% 0.01% $6,358,098
AYAL Capital Advisors Ltd 1.4% 265,000 +27% 3.2% $5,784,950
Potomac Capital Management, Inc. 0.86% 161,400 0% 2.9% $3,523,362
JANE STREET GROUP, LLC 0.85% 159,014 +276% 0% $3,471,275
Beartown Capital Management, LLC 0.77% 145,000 0% 2.5% $3,165,350
BANK OF AMERICA CORP /DE/ 0.76% 143,124 +4.9% 0% $3,124,397
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.74% 138,677 +0.43% 0% $3,027,319
TUDOR INVESTMENT CORP ET AL 0.67% 124,943 -2.9% 0.01% $2,727,506
Qube Research & Technologies Ltd 0.66% 124,646 -39% 0% $2,721,022
GOLDMAN SACHS GROUP INC 0.66% 124,630 -24% 0% $2,720,673
NORTHERN TRUST CORP 0.61% 114,262 -2.3% 0% $2,494,339
MORGAN STANLEY 0.58% 109,445 +51% 0% $2,389,185

Institutional Holders of Anterix Inc. - Common Stock (ATEX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,878,853 $71,750,496 -$2,640,228 $38.19 45
2025 Q4 16,180,534 $353,310,211 -$760,647 $21.83 116
2025 Q3 15,892,445 $341,210,062 -$21,494,095 $21.47 110
2025 Q2 16,798,194 $430,873,693 +$5,778,849 $25.65 109
2025 Q1 16,354,227 $598,597,088 +$24,643,665 $36.60 128
2024 Q4 15,990,167 $490,412,835 +$4,179,537 $30.67 113
2024 Q3 15,762,630 $593,586,930 +$33,544,074 $37.66 127
2024 Q2 14,976,662 $592,922,823 +$12,607,148 $39.59 112
2024 Q1 14,671,486 $493,164,901 -$3,442,304 $33.61 97
2023 Q4 14,774,749 $492,294,457 -$2,514,906 $33.32 91
2023 Q3 14,875,879 $466,805,252 -$14,453,049 $31.38 96
2023 Q2 15,334,359 $485,963,452 -$3,134,853 $31.69 93
2023 Q1 15,429,877 $509,799,258 -$1,255,532 $33.04 86
2022 Q4 15,489,687 $498,309,599 -$9,985,557 $32.17 91
2022 Q3 15,717,231 $561,424,047 +$25,584,069 $35.72 96
2022 Q2 14,954,246 $614,165,320 -$5,584,480 $41.07 90
2022 Q1 15,103,375 $874,447,504 -$6,381,270 $57.90 105
2021 Q4 15,187,749 $892,021,662 -$15,273,036 $58.76 102
2021 Q3 15,139,014 $918,125,236 -$783,490 $60.70 105
2021 Q2 15,202,979 $912,028,428 -$9,533,969 $59.99 106
2021 Q1 15,500,931 $731,032,284 +$49,980,240 $47.16 96
2020 Q4 16,188,659 $608,687,656 +$12,279,881 $37.60 86
2020 Q3 15,950,453 $521,738,240 -$14,474,223 $32.71 92
2020 Q2 16,236,389 $736,140,456 -$10,250,900 $45.34 101
2020 Q1 16,462,443 $751,832,615 -$24,859,764 $45.67 80
2019 Q4 16,221,458 $700,437,489 +$111,171,052 $43.21 76
2019 Q3 13,668,174 $494,780,224 +$492,846,807 $36.20 71
2019 Q2 53,408 $2,511,000 +$2,511,000 $47.02 2
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .